Last March, Danielle — a 38-year-old paralegal in Austin — started Ozempic after years of what she calls “the loop.” Diet, lose twenty pounds, regain twenty-five, hate herself quietly, repeat. Within six weeks, something strange happened. Not the weight loss — she’d expected that. What she hadn’t expected was the 6 a.m. walks. Then the yoga class. Then the kettlebell she ordered off Amazon at midnight on a Tuesday. “I’ve owned gym memberships I never used for literally a decade,” she told me. “Suddenly I wanted to move. Not to burn calories. Just — to move.”
Her doctor wasn’t surprised. Danielle was.
This pattern — people on GLP-1 receptor agonists like semaglutide and tirzepatide spontaneously adopting exercise habits they’d never been able to sustain — keeps showing up in clinical data and, more tellingly, in the anecdotal chorus of online communities. A 2023 study published in Obesity found that participants on semaglutide increased their physical activity levels significantly more than placebo groups, even when exercise wasn’t a prescribed component of the trial. The drug wasn’t telling them to work out. Something else was happening.
And what it reveals about motivation is — frankly — a little destabilizing if you’ve spent your life believing willpower is a character trait.
The standard narrative around weight loss has always been mechanical: calories in, calories out, discipline as the engine. We treat motivation like a moral resource — something you either have or you don’t. “Lazy” is a diagnosis we hand out freely. But what Danielle’s experience — and thousands like hers — suggests is that motivation isn’t the cause of action. It’s often the result of removing invisible barriers.
Psychologists have a concept for this: behavioral activation threshold — the internal cost of initiating an action. For someone carrying significant weight, chronic inflammation, joint pain, poor sleep, and the neurochemical noise of disordered hunger signals all conspire to make the threshold for exercise brutally high. Not because the person is weak. Because the system is loaded against them.
Marcus, a 45-year-old IT manager in Columbus, put it this way: “People think I didn’t exercise because I didn’t care. I didn’t exercise because by 5 p.m. every day, my body felt like it was wearing a lead suit. Three months on tirzepatide, the suit came off. I didn’t become a different person. I became the person I already was without the weight crushing every impulse.”
That distinction matters enormously.
There’s a cultural mythology — especially potent in wellness spaces — that authentic change must come from within, from some pure internal reckoning. As I explored in a piece about the performances we maintain for people we love, we are deeply invested in the idea that identity is fixed — that who we are at the table is who we really are. But identity is far more fluid and context-dependent than we admit. Remove the thing that was draining someone’s neurological bandwidth, and behaviors that looked impossible suddenly become obvious.
This isn’t unique to weight loss drugs. It’s the same phenomenon behind why people who get treatment for depression suddenly start cleaning their apartments, returning phone calls, going for walks. The depression wasn’t caused by a messy apartment. The messy apartment was a symptom of a system under siege. Treat the siege, and the downstream behaviors reorganize themselves — often without conscious effort.
Researchers at the University of Pennsylvania have described this as cognitive liberation — the mental bandwidth that becomes available when a chronic stressor is reduced. A 2023 review in The Lancet Diabetes & Endocrinology noted that GLP-1 agonists appear to reduce not just appetite but the “food noise” — the constant, intrusive mental preoccupation with eating that many people with obesity describe. When that noise quiets, what rushes in isn’t emptiness. It’s capacity.
Priya, a 52-year-old high school principal in Minneapolis, described it as getting her “brain back.” She’d spent decades assuming she was simply someone who lacked discipline around food and fitness. “I have a doctorate in education,” she said, laughing. “I run a school with 1,800 students. Discipline was never the problem. Something was hijacking my ability to act on what I already knew.”
This reframing has implications far beyond pharmacology. It challenges the entire motivational-industrial complex — the billion-dollar ecosystem of productivity hacks, accountability coaches, and inspirational Instagram reels that presuppose the problem is always you not trying hard enough. As we’ve discussed in the surprising simplicity behind effective financial habits, sometimes the breakthrough isn’t a more sophisticated strategy. It’s removing the thing that made the simple strategy feel impossible.
There’s a parallel in how we think about relationships, too. The hidden dynamics in one-sided reaching out often aren’t about one person caring less — they’re about asymmetric loads. One person is carrying something invisible that makes reciprocity feel like climbing a wall. Reduce the load, and the reaching out starts flowing both ways. Same principle. Different domain.
None of this means the drugs are magic, or that everyone’s experience mirrors Danielle’s or Marcus’s or Priya’s. Side effects are real. Access is inequitable. The long-term data is still emerging. And there are legitimate questions about what happens when people stop taking them — whether the behavioral changes persist or whether they were, in some sense, rented rather than owned.
But here’s what I keep coming back to.
We have spent decades treating motivation as a prerequisite for change. What if it’s actually a consequence of change — a signal that the conditions for action have finally become hospitable? What if the thing we’ve been calling laziness in millions of people was never a character flaw but a rational response to an overwhelmed system?
The uncomfortable truth isn’t that these drugs “give” people motivation. It’s that motivation was always there — buried under neurochemical noise, chronic pain, systemic inflammation, and a culture that interpreted all of it as moral failure. The drugs didn’t install new software. They cleared the malware that was eating up all the processing power.
That’s not a story about pharmaceuticals. That’s a story about how profoundly we have misunderstood what it means to be stuck — and how much shame we’ve heaped on people for a problem that was never about wanting it badly enough. As explored in what genuine resilience actually looks like, the people who’ve endured the most aren’t the ones who never struggled. They’re the ones who kept existing inside the struggle — long before anyone offered them a way through.
Danielle still walks at 6 a.m. She says it’s the first thing in years that feels like it belongs to her — not to a diet plan, not to a punishment cycle, not to the version of herself she was performing for everyone else. Just movement. Just her body doing what it wanted to do all along, once it finally could.
Maybe that’s what motivation actually is. Not a fire you light. A door you unlock.
Feature image by Leeloo The First on Pexels
